Critical roles of CD30/CD30L interactions in murine autoimmune diabetes

Clinical and Experimental Immunology

Volumn 133, Issue 3, 2003, Pages 318-325

  Chakrabarty, S ^a   Nagata, Masao ^a   Yasuda, H ^c   Wen, L ^c   Nakayama, M ^a   Chowdhury, S A ^a   Yamada, K ^a   Jin, Z ^a   Kotani, R ^a   Moriyama, H ^a   Shimozato, O ^b   Yagita, H ^b   Yokono, K ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunotherapy; Monoclonal antibody; NOD mouse; TNF superfamily; Type 1 diabetes

Indexed keywords

CD30 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; LIGAND; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOREGULATION; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET CELL; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD30; AUTOIMMUNE DISEASES; CD30 LIGAND; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; ISLETS OF LANGERHANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0041825571     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02223.x     Document Type: Article

References (39)

1. Eisenbarth GS. Type I diabetes: a chronic autoimmune disease. N Eng J Med 1986; 314:1360-8.
2. Stiller CR, Dupre J, Gent M et al. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984; 223:1362-7.
3. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331:1428-36.
4. Roep BO, Arden SD, de Vries RR et al. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 1990; 345:632-4.
5. Roep BO, Kallan AA, Hazenbos WL et al. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 1991; 337:1439-41.
6. Panina-Bordignon P, Lang R, van Endert PM et al. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 1995; 181:1923-7.
7. Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347:151-6.
8. Rabin DU, Pleasic SM, Shapiro JA et al. Islet cell antigen 512 is a diabetic-specific islet autoantigen related to protein tyrosin phosphateses. J Immunol 1994; 152:3183-91.
9. Dean BM, Pujol-Borrel R, Botazzo GF. Determination of islet cell antibodies by immunofluorescence. Lancet 1982; 2:1343-7.
10. Lan MS, Lu J, Goto Y et al. Molecular cloning and identification of a relation type protein tyrosin phosphatase, IA-2 from human insulinoma. DNA Cell Biol 1994; 13:505-14.
11. Palmer JP, Asplin CM, Clemons P et al. Insulin antibodies in insulin-dependent diabetes before insulin treatment. Science 1983; 222:1337-9.
12. Delovitch TL, Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997; 7:727-38.
13. Lenschow DJ, Ho SC, Sattar H et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mice. J Exp Med 1995; 181:1145-55.
14. Moriyama H, Yokono K, Amano K et al. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. J Immunol 1996; 157:3737-43.
15. Balasa B, Krahl T, Patstone G et al. CD40 ligand-CD40 interactioins are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol 1997; 159:4620-7.
16. Arens R, Tesselaar K, Baars PA et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFN-gamma-mediated B cell depletion. Immunity 2001; 15:801-12.
17. Morimoto S, Kanno Y, Tanaka Y et al. CD134L engagement enhances human B cell Ig production. CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses. J Immunol 2000; 164:4097-104.
18. Schwab U, Stein H, Gerdes J et al. Production of monoclonal antiboby specific for Hodge and Reed-Sternberg cells of Hodgekin disease and a subset of normal lymphoid cells. Nature 1982; 299:65-71.
19. Smith CA, Gruss HJ, Davis T et al. CD30 antigen, a marker for Hodgekin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1999; 73:1349-60.
20. Seko Y, Takahashi N, Oshima H et al. Expression of tumour necrosis factor (TNF) receptor/ligand superfamily co-stimulatory molecules CD40, CD30L, CD27L, and OX40L in murine hearts with chronic ongoing myocarditis caused by coxsackie virus B3. J Pathol 1999; 188:423-30.
21. Shanebeck KD, Maliszewski CR, Kennedy MK et al. Regulation of murine B cell growth and differtiation by CD30 ligand. Eur J Immunol 1995; 25:2147-53.
22. Gruss HJ, Boiani N, Williams DE et al. Pleotropic effects of the CD30 ligand on CD30 expressing cells and lymphoma cell lines. Blood 1994; 83:2045-56.
23. Bowen MA, Olsen KJ, Cheng L et al. Functional effect of CD30 on a large granular lymphoma cell line, YT. Inhibition of cytotoxicity, regulation of CD28 and IL-2R and induction of homotypic aggregation. J Immunol 1993; 151:5896-906.
24. Gerli R, Pitzalis C, Bistoni O et al. CD30+ T cells in rheumatoid synovitis, mechanisms of recruitment and functional role. J Immunol 2000; 164:4399-407.
25. Saraiva M, Smith P, Fallon PG et al. Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. J Exp Med 2002; 196:829-39.
26. Kurts C, Carbone FR, Krummel MF et al. Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature 1999; 398:341-4.
27. Kurts C, Carbone FR, Krummel MF et al. Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature 2000; 407:413.
28. Seigmund T, Armitage N, Wicker LS et al. Analysis of the mouse CD30 gene; A candidate for the NOD mouse type 1 diabetes locus IDD9. 2 Diabetes 2000; 49:1612-6.
29. Yoneda R, Yokono K, Nagata M et al. CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class 1- compatible scid mice. Diabetologia 1997; 40:1044-52.
30. Nakayama M, Nagata M, Yasuda H et al. Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes. Diabetes 2002; 51:1391-7.
31. Shimozato O, Takeda K, Yagita H et al. Expression of CD30 ligand (CD153) on murine activated T cells. Biochem Biophys Res Commun 1999; 256:519-26.
32. Caligaris-Cappio F, Bertero MT, Converso M et al. Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with SLE and correlate with disease activity. Clin Exp Rheumatol 1995; 13:339-43.
33. Gerli R, Muscat C, Bistoni O et al. High level of the soluble form of CD30 molecules in rheumatoid arthritis are expression of CD30+T cell involvement in the inflamed joints. Clin Exp Immunol 1995; 102:547-50.
34. Okumura M, Hidaka Y, Kuroda S et al. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 1997; 82:1757-60.
35. Wicker LS, Leiter EH, Todd JA et al. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 1994; 43:500-4.
36. Serreze DV, Chapman HD, Varnum DS et al. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J Immunol 1997; 158:3978-86.
37. Wong FS, Visintin I, Wen L et al. CD8 T-cell clones from young non-obese diabetic (NOD) can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 1996; 183:67-76.
38. Wong FS, Karttunen J, Dumont C et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med 1999; 5:1026-31.
39. Opat S, Gaston JS. CD30:CD30L interactions in the immune response. Autoimmunity 2001; 33:45-60.